Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.310
+0.005 (1.64%)
At close: Nov 21, 2024, 4:00 PM
0.301
-0.009 (-2.87%)
After-hours: Nov 21, 2024, 6:44 PM EST
Cara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -95.53 | -118.51 | -85.47 | -88.44 | 8.41 | -106.37 | |
| Depreciation & Amortization | 0.27 | 0.26 | 1.67 | 1.55 | 1.02 | 0.8 | |
| Loss (Gain) From Sale of Assets | - | - | - | -0.07 | - | - | |
| Asset Writedown & Restructuring Costs | 4.27 | - | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -0.78 | -0.4 | 0.26 | 0.82 | -0.12 | -1.38 | |
| Stock-Based Compensation | 10.18 | 13.73 | 17.73 | 20.79 | 14.84 | 12.57 | |
| Other Operating Activities | 10.59 | 2.68 | - | - | -22.26 | -15.75 | |
| Change in Accounts Receivable | 2.92 | 0.5 | -3.26 | - | - | -0.05 | |
| Change in Inventory | 0.13 | -0.44 | 0.2 | -2.58 | - | - | |
| Change in Accounts Payable | -15.91 | 3.28 | 5.68 | -1.02 | -2.78 | 6.04 | |
| Change in Income Taxes | 0.7 | - | - | 0.81 | -0.69 | -0.15 | |
| Change in Other Net Operating Assets | 8.92 | 6.84 | -15.54 | 8.06 | -3.89 | -4.94 | |
| Operating Cash Flow | -74.24 | -92.08 | -78.73 | -60.09 | -5.49 | -109.23 | |
| Capital Expenditures | -3.1 | -2.38 | -0.04 | -0.04 | -0.35 | -0.02 | |
| Sale of Property, Plant & Equipment | - | - | - | 0.07 | - | - | |
| Investment in Securities | 16.63 | 45.84 | 128.75 | -4.78 | -19.93 | -30.5 | |
| Investing Cash Flow | 13.54 | 43.46 | 128.71 | -4.75 | -20.28 | -30.52 | |
| Issuance of Common Stock | 0 | 1.68 | 0.31 | 46.61 | 39.14 | 142.6 | |
| Other Financing Activities | 34.49 | 36.47 | - | - | - | - | |
| Financing Cash Flow | 34.49 | 38.15 | 0.31 | 46.61 | 39.14 | 142.6 | |
| Net Cash Flow | -26.22 | -10.47 | 50.29 | -18.23 | 13.38 | 2.86 | |
| Free Cash Flow | -77.34 | -94.45 | -78.77 | -60.13 | -5.84 | -109.24 | |
| Free Cash Flow Margin | -890.42% | -450.46% | -188.15% | -261.10% | -4.32% | -549.35% | |
| Free Cash Flow Per Share | -1.41 | -1.74 | -1.47 | -1.19 | -0.12 | -2.56 | |
| Levered Free Cash Flow | -54.33 | -52.53 | -46.93 | -26.51 | -9.67 | -58.86 | |
| Unlevered Free Cash Flow | -50.29 | -52.16 | -46.93 | -26.51 | -9.67 | -58.86 | |
| Change in Net Working Capital | -0.42 | -12.16 | 11.58 | -6.87 | 28.54 | 2.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.